Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$492M |
| 2 |
Meta Platforms (Facebook)
META
|
+$323M |
| 3 |
Linde
LIN
|
+$297M |
| 4 |
Adobe
ADBE
|
+$279M |
| 5 |
Danaher
DHR
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$759M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$424M |
| 4 |
Amazon
AMZN
|
+$372M |
| 5 |
Accenture
ACN
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 14.09% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.74% |
| 5 | Industrials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGNT
1326
AGNT Inc
AGNT
$664M
| $136K | ﹤0.01% |
7,788
-658
| -8% | -$17.2K |
|
1327
iShares US Medical Devices ETF
IHI
$3.02B
| $136K | ﹤0.01% |
2,190
| – | – |
|
1328
Twist Bioscience
TWST
$5.62B
| $136K | ﹤0.01% |
2,821
-239
| -8% | -$13.2K |
|
1329
STAAR Surgical
STAA
$1.16B
| $134K | ﹤0.01% |
1,848
-1,087
| -37% | -$81K |
|
|
BPMC
1330
DELISTED
Blueprint Medicines
BPMC
| $133K | ﹤0.01% |
1,948
| – | – |
|
1331
PENN Entertainment
PENN
$2.74B
| $133K | ﹤0.01% |
3,524
-160,837
| -98% | -$7.35M |
|
1332
Stratasys
SSYS
$697M
| $132K | ﹤0.01% |
+5,779
| New | +$139K |
|
|
LOGC
1333
DELISTED
ContextLogic
LOGC
| $132K | ﹤0.01% |
2,067
+1,440
| +230% | +$102K |
|
|
LPRO
1334
Open Lending Corp
LPRO
$373M
| $131K | ﹤0.01% |
7,705
| – | – |
|
1335
Millicom
TIGO
$15.8B
| $131K | ﹤0.01% |
4,880
-1,126
| -19% | -$29K |
|
|
AMRS
1336
DELISTED
Amyris Inc.
AMRS
| $130K | ﹤0.01% |
+29,048
| New | +$130K |
|
|
ONEM
1337
DELISTED
1Life Healthcare
ONEM
| $128K | ﹤0.01% |
11,846
+5,147
| +77% | +$57.6K |
|
1338
HealthStream
HSTM
$793M
| $126K | ﹤0.01% |
6,248
| – | – |
|
1339
JetBlue
JBLU
$1.96B
| $126K | ﹤0.01% |
+10,400
| New | +$151K |
|
1340
Option Care Health
OPCH
$3.4B
| $126K | ﹤0.01% |
+4,432
| New | +$111K |
|
1341
Sprouts Farmers Market
SFM
$7.04B
| $126K | ﹤0.01% |
3,745
-2,488
| -40% | -$74.4K |
|
|
MNDT
1342
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $125K | ﹤0.01% |
5,600
| – | – |
|
|
AXIA
1343
AXIA Energia
AXIA
$22.6B
| $124K | ﹤0.01% |
18,429
-223,497
| -92% | -$1.15M |
|
1344
KRONOS Worldwide
KRO
$761M
| $124K | ﹤0.01% |
+8,000
| New | +$119K |
|
1345
StoneCo
STNE
$2.62B
| $122K | ﹤0.01% |
10,913
-41,329
| -79% | -$540K |
|
1346
Insmed
INSM
$23.2B
| $121K | ﹤0.01% |
4,918
| – | – |
|
1347
Beam Therapeutics
BEAM
$2.58B
| $120K | ﹤0.01% |
2,255
| – | – |
|
1348
LendingTree
TREE
$544M
| $120K | ﹤0.01% |
1,078
| – | – |
|
1349
International Bancshares
IBOC
$4.77B
| $119K | ﹤0.01% |
+2,955
| New | +$127K |
|
|
ACCD
1350
DELISTED
Accolade Inc
ACCD
| $118K | ﹤0.01% |
+7,374
| New | +$136K |
|
Similar funds
Amundi's Q1 2022 Portfolio in Review
As of Q1 2022, Amundi held 1,764 positions worth $148B, down 6.4% from $158B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Amundi's Q1 2022 filing shows 103 new, 607 increased, 690 reduced and 109 closed positions. Its largest new stake was Shell: 1,425,919 shares worth $79M. The largest sale was Apple, an estimated $793M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Amundi's largest Q1 2022 buy was Shell: 1,425,919 shares worth $79M.
- Amundi added most to NVIDIA in Q1 2022, an estimated $492M increase.
- Amundi's biggest Q1 2022 reduction was Apple, cutting an estimated $793M.
- Amundi fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $169M.
- Amundi's ten largest holdings make up 18% of its $148B portfolio in Q1 2022.
- Amundi opened 103 new positions and closed 109 in Q1 2022.
- Amundi's portfolio value fell 6.4% quarter-over-quarter to $148B.
Based on Amundi's 13F filing for Q1 2022, filed 16 May 2022.